Hims & Hers Health announced the expansion of its Board of Directors from nine to ten members with the appointment of Deb Autor, 57, as an independent director, effective November 15, 2024. Autor will serve until the company's 2025 annual meeting of stockholders and has been appointed to the Board's Risk Committee alongside Christopher Payne, Anja Manuel, Kåre Schultz, and David Wells.In conjunction with her board appointment, Autor has entered into a one-year consulting agreement with the company, under which she will receive a consulting fee of $100,000. The agreement includes standard termination provisions, requiring 30 days' notice for termination without cause and 15 days' notice for material breach. The Board has confirmed that Autor meets all independence requirements under NYSE listing standards and Securities Exchange Act regulations.

Hims & Hers Health announced the expansion of its Board of Directors from nine to ten members with the appointment of Deb Autor, 57, as an independent director, effective November 15, 2024. Autor will serve until the company's 2025 annual meeting of stockholders and has been appointed to the Board's Risk Committee alongside Christopher Payne, Anja Manuel, Kåre Schultz, and David Wells.In conjunction with her board appointment, Autor has entered into a one-year consulting agreement with the company, under which she will receive a consulting fee of $100,000. The agreement includes standard termination provisions, requiring 30 days' notice for termination without cause and 15 days' notice for material breach. The Board has confirmed that Autor meets all independence requirements under NYSE listing standards and Securities Exchange Act regulations.